DanPET AB
556880-4388ActiveDeveloping PET ligands, biomarkers, and medicines for unmet needs.
Biotechnology Companydanpet.eu
Översikt
- Okänt
- Anställda
- Okänt
- Omsättning
- 2012
- Grundat
Nyckelbeslutsfattare
Dan Peters
Chief Executive Officer
@danpet.eu
Beskrivning
DanPET AB is a translational biotechnology company focused on innovation in healthcare. Its core mission is to develop novel biomarkers and future medicines addressing significant unmet medical needs. This development work is consistently performed in close collaboration with world-leading partners...
Taggar
B2B
Nyckelord
Biomarkers